Tevard Biosciences - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTevard Biosciences
Tevard Biosciences logo

Tevard Biosciences

0 followers

About Tevard Biosciences

Tevard Biosciences is a biotechnology company focused on developing gene therapy approaches, specifically tRNA-based therapies, to cure rare genetic diseases. The organization emphasizes suppressor tRNA technologies to restore full-length proteins across multiple disease targets, including cardiac and muscular disorders, using AAV delivery and basket-style clinical strategies. Based in the United States, with leadership rooted in prominent academic and biotech backgrounds, the company aims to translate transformative genetic therapies into durable cures for patients with nonsense mutations.

Recent News

Recent Deals

No recent deals for this company.

Key Facts

HQ Location

Cambridge, United States

Founded

2020

Employees

11 - 50

Status

Private

Website

https://tevard.com